0001493152-20-017668.txt : 20200911
0001493152-20-017668.hdr.sgml : 20200911
20200911182200
ACCESSION NUMBER: 0001493152-20-017668
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200911
FILED AS OF DATE: 20200911
DATE AS OF CHANGE: 20200911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schreiber Christopher C
CENTRAL INDEX KEY: 0001750076
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36268
FILM NUMBER: 201171913
MAIL ADDRESS:
STREET 1: AKERS BIOSCIENCES, INC.
STREET 2: 201 GROVE ROAD
CITY: THOROFARE
STATE: NJ
ZIP: 08086
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akers Biosciences, Inc.
CENTRAL INDEX KEY: 0001321834
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 GROVE RD
CITY: THOROFARE
STATE: NJ
ZIP: 08086
BUSINESS PHONE: 856-848-8698
MAIL ADDRESS:
STREET 1: 201 GROVE RD
CITY: THOROFARE
STATE: NJ
ZIP: 08086
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences Inc
DATE OF NAME CHANGE: 20050325
4
1
ownership.xml
X0306
4
2020-09-11
0
0001321834
Akers Biosciences, Inc.
AKER
0001750076
Schreiber Christopher C
C/O TAGLICH BROTHERS INC
709 NEW YORK AVENUE, SUITE 209
HUNTINGTON
NY
11743
1
1
0
0
Exec. Chairman and President
Restricted Stock Unit
2020-09-11
4
A
0
263500
0
A
Common Stock
263500
263500
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the "Company"). The Company may also elect to settle the vested RSUs for cash at its discretion.
Reporting Person was granted 263,500 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the "Plan"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause.
/s/ Christopher C. Schreiber
2020-09-11